Any current/future new fundraising through debt or equity?

There is no specific mention in the transcript regarding any current or future fundraising plans through debt or equity. The company has been managing its borrowings by scheduled term loan repayments, reducing term lending borrowings by ₹62 crores. An outstanding working capital loan of ₹39.5 crores was availed in the weak quarter to support operations. The company reported refinancing benefits leading to significant reduction in interest costs compared to the previous year. No indication was given about raising new funds through equity or additional debt during the call or in the transcript.

Any current/future capex/capital investment/strategic investment?

The company commissioned and capitalized its CPVC plant on October 31, with gradual ramp-up expected in Q3 and full production and sales from Q4 onwards. Total CAPEX for CPVC and SIOP projects is guided to be within ₹125 crores, with the CWIP as of September 30 standing at around ₹110-111 crores. Maintenance CAPEX will keep CWIP around ₹10-12 crores by year-end. The company signed a 20-year power purchase agreement with Clean Tech Solar to set up a 44 MW solar plant in Tamil Nadu under a group captive structure, expected to be commissioned by the end of Q1 next year, aiming to reduce power cos

Future growth expectations in sales/revenue/volumes?

Gradual ramp-up of new CPVC capacity expected from Q3 FY24, with full production and sales from Q4 FY24 onwards. CPVC volumes have increased quarter-on-quarter; however, realizations have dropped due to price corrections. Specialty chemicals (CPVC & SIOP) maintain strong margins north of 35%, with increasing SIOP sales volumes. Overall, improvement in export demand and additional CPVC volumes are positive growth factors expected in H2 FY24. Total production of caustic soda is planned to increase from current 20,000 tonnes to about 30,000 tonnes shortly. PVC volumes and margins expected to bene

Future growth expectations in earnings/operating earnings/profits/EPS?

Management expects gradual improvement in earnings and EBITDA from Q3 FY24 onwards, driven by the ramp-up of the new CPVC capacity and increased specialty chemical volumes (CPVC and SIOP). Specialty products (CPVC and SIOP) continue to deliver strong EBITDA margins north of 35%, supporting future profitability. Anticipated increase in PVC prices from Q4 FY24 is expected to improve margins, stabilizing earnings. Caustic soda prices and utilization expected to improve gradually due to supply-side compression and correction in global demand, contributing positively to profits. EBITDA for full FY2

DCWQ2 FY24Chemicals & Petrochemicals

DCW Q2 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹44.6P/E: 20.2Market Cap: ₹1.4K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

Gradual ramp-up of new CPVC capacity expected from Q3 FY24, with full production and sales from Q4 FY24 onwards.
CPVC volumes have increased quarter-on-quarter; however, realizations have dropped due to price corrections.
Specialty chemicals (CPVC & SIOP) maintain strong margins north of 35%, with increasing SIOP sales volumes.
Overall, improvement in export demand and additional CPVC volumes are positive growth factors expected in H2 FY24.
Total production of caustic soda is planned to increase from current 20,000 tonnes to about 30,000 tonnes shortly.
PVC volumes and margins expected to benefit from potential price increase anticipated around Q4 FY24.
Soda ash production constrained due to mechanical issues; expected to remain under capacity for the year.
Management targets EBITDA growth with confidence of achieving over ₹300 crore EBITDA in FY24, implying revenue growth is aligned with margin focus.

Margin guidance

Category 3

Management expects gradual improvement in earnings and EBITDA from Q3 FY24 onwards, driven by the ramp-up of the new CPVC capacity and increased specialty chemical volumes (CPVC and SIOP).
Specialty products (CPVC and SIOP) continue to deliver strong EBITDA margins north of 35%, supporting future profitability.
Anticipated increase in PVC prices from Q4 FY24 is expected to improve margins, stabilizing earnings.
Caustic soda prices and utilization expected to improve gradually due to supply-side compression and correction in global demand, contributing positively to profits.
EBITDA for full FY24 was initially targeted at Rs. 300 crore; current H1 EBITDA at Rs. 101 crore, but management remains confident of achieving the target despite earlier commodity price pressures.
Contingent liabilities reduced by Rs. 58 crore, positively impacting future earnings.
The operational focus is on EBITDA growth rather than top-line expansion in FY24.

See what DCW management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no specific mention in the transcript regarding any current or future fundraising plans through debt or equity.
The company has been managing its borrowings by scheduled term loan repayments, reducing term lending borrowings by ₹62 crores.
An outstanding working capital loan of ₹39.5 crores was availed in the weak quarter to support operations.
The company reported refinancing benefits leading to significant reduction in interest costs compared to the previous year.
No indication was given about raising new funds through equity or additional debt during the call or in the transcript.

Order book

The transcript does not provide specific details on the current or expected order book or pending orders for DCW Limited. However, relevant insights include: - Early green shoots of demand improvement were noted for CPVC and specialty orders, indicating potential future order inflows. - The company mentioned incremental SIOP volumes expected to come in the second half. - Demand for TiO2 and titanium metal remains strong, suggesting steady order flow in that segment. - The management expects better market conditions and export demand improvement in the coming quarters. - Some recovery in trade and volumes for SR (Synthetic Rutile) indicated, with early signs of orders coming in. For precise and detailed order book information, the company suggests reaching out to Investor Relations for further data.

See what DCW management said on order book — free account, 30 seconds.

Capex plans

Yes

The company commissioned and capitalized its CPVC plant on October 31, with gradual ramp-up expected in Q3 and full production and sales from Q4 onwards.
Total CAPEX for CPVC and SIOP projects is guided to be within ₹125 crores, with the CWIP as of September 30 standing at around ₹110-111 crores.
Maintenance CAPEX will keep CWIP around ₹10-12 crores by year-end.
The company signed a 20-year power purchase agreement with Clean Tech Solar to set up a 44 MW solar plant in Tamil Nadu under a group captive structure, expected to be commissioned by the end of Q1 next year, aiming to reduce power costs and increase green power usage.
No further significant additions to contingent liabilities or other strategic investments were explicitly mentioned beyond ongoing projects.

Track DCW — get its next earnings analysis in your feed

How does DCW rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisDCW

Rev 4Mar 3

See where DCW sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does DCW rank in Chemicals & Petrochemicals?

Compare DCW against every Chemicals & Petrochemicals company (Q2 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What DCW's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Prasol Chemicals Ltd (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹433.6 crores . Key investor presentation takeaways from Prasol Chemicals Ltd's Q1 FY27 investor presentation — and how it rank
Vipul Organics Ltd (Q4 FY26)
Q4 FY26 (Mar 2026) total revenue: ₹5,262.37 lakhs (Consolidated) . Key concall takeaways from Vipul Organics's Q4 FY26 earnings call — and how it ranks against…
Vipul Organics Ltd (Q1 FY27)
Q1 FY27 net revenue: ₹51.78 crore, up +37.7% YoY (Page 13) . Key concall takeaways from Vipul Organics's Q1 FY27 earnings call — and how it ranks against…
Fine Organic Industries Ltd (Q1 FY27)
Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key concall takeaways from Fine Organic…

Compare:vs Solar Industries India Ltd vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →